Christine B. Weldon

970 total citations
92 papers, 684 citations indexed

About

Christine B. Weldon is a scholar working on Economics and Econometrics, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Christine B. Weldon has authored 92 papers receiving a total of 684 indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Economics and Econometrics, 34 papers in Oncology and 29 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Christine B. Weldon's work include Economic and Financial Impacts of Cancer (36 papers), BRCA gene mutations in cancer (16 papers) and Global Cancer Incidence and Screening (16 papers). Christine B. Weldon is often cited by papers focused on Economic and Financial Impacts of Cancer (36 papers), BRCA gene mutations in cancer (16 papers) and Global Cancer Incidence and Screening (16 papers). Christine B. Weldon collaborates with scholars based in United States, Germany and United Kingdom. Christine B. Weldon's co-authors include Julia R. Trosman, Kathryn A. Phillips, Michael P. Douglas, Al B. Benson, William J. Gradishar, Robin Kate Kelley, Julian C. Schink, Patricia A. Deverka, Allison W. Kurian and Tatjana Kolevska and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Nature Biotechnology.

In The Last Decade

Christine B. Weldon

81 papers receiving 669 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christine B. Weldon United States	16	249	197	197	193	167	92	684
Julia R. Trosman United States	19	230 0.9×	211 1.1×	287 1.5×	282 1.5×	209 1.3×	91	868
Pamela Kadlubek United States	11	225 0.9×	247 1.3×	107 0.5×	151 0.8×	51 0.3×	21	543
M. Chandler McLeod United States	14	195 0.8×	112 0.6×	225 1.1×	56 0.3×	163 1.0×	41	708
Caroline S. Bennette United States	14	121 0.5×	102 0.5×	190 1.0×	211 1.1×	114 0.7×	24	561
Electra D. Paskett United States	6	576 2.3×	160 0.8×	177 0.9×	64 0.3×	221 1.3×	11	810
Anne‐Gaëlle Le Corroller France	17	323 1.3×	131 0.7×	81 0.4×	74 0.4×	81 0.5×	44	718
C. Klabunde United States	12	430 1.7×	220 1.1×	154 0.8×	128 0.7×	62 0.4×	16	767
Ellen G. Engelhardt Netherlands	15	260 1.0×	157 0.8×	99 0.5×	64 0.3×	182 1.1×	43	749
Bobby Daly United States	12	314 1.3×	121 0.6×	94 0.5×	63 0.3×	134 0.8×	31	564
R. Ryanne Wu United States	14	144 0.6×	118 0.6×	228 1.2×	73 0.4×	53 0.3×	33	532

Countries citing papers authored by Christine B. Weldon

Since Specialization

Citations

This map shows the geographic impact of Christine B. Weldon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christine B. Weldon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christine B. Weldon more than expected).

Fields of papers citing papers by Christine B. Weldon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christine B. Weldon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christine B. Weldon. The network helps show where Christine B. Weldon may publish in the future.

Co-authorship network of co-authors of Christine B. Weldon

This figure shows the co-authorship network connecting the top 25 collaborators of Christine B. Weldon. A scholar is included among the top collaborators of Christine B. Weldon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christine B. Weldon. Christine B. Weldon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kircher, Sheetal, et al.. (2024). Oncologic drug repository programs in the United States: a review and comparison. Health Affairs Scholar. 2(3). qxae031–qxae031. 1 indexed citations

Weldon, Christine B., Julia R. Trosman, Bruce D. Rapkin, et al.. (2024). Right Information, Right Care, Right Patient, Right Time: Community Preferences to Inform a Self-Management Support Tool for Upper Respiratory Symptoms. Applied Clinical Informatics. 16(1). 145–155. 1 indexed citations

Weldon, Christine B., et al.. (2024). Information and support needs of young Black women with early breast cancer to enable self-management and informed decisions during breast cancer treatment.. Journal of Clinical Oncology. 42(16_suppl). e12587–e12587.

Wei, Jenny, Nancy Goler, Christine B. Weldon, et al.. (2023). The voice of the breast cancer survivor: Implementation of survivorship needs assessment in an integrated health system.. Journal of Clinical Oncology. 41(16_suppl). e24180–e24180. 1 indexed citations

Wei, Jenny, Juraj Kavecansky, Yan Li, et al.. (2023). The implementation of a self-care tool for patients that may reduce clinician burden.. Journal of Clinical Oncology. 41(16_suppl). 11017–11017.

Wei, Jenny, Christine B. Weldon, Julia R. Trosman, et al.. (2023). The impact of the 4R Oncology model on OncotypeDx turnaround time.. Journal of Clinical Oncology. 41(16_suppl). 531–531.

Trosman, Julia R., Christine B. Weldon, Allison W. Kurian, et al.. (2023). Perspectives of private payers on multicancer early-detection tests: informing research, implementation, and policy. Health Affairs Scholar. 1(1). qxad005–qxad005. 9 indexed citations

Liu, Raymond, Christine B. Weldon, Nancy P. Gordon, et al.. (2022). Fostering a High-Functioning Team in Cancer Care Using the 4R Oncology Model: Assessment in a Large Health System and a Blueprint for Other Institutions. JCO Oncology Practice. 19(1). e125–e137. 6 indexed citations

Guenther, William C., Bryan S. Jordan, Leigh Boehmer, et al.. (2022). Assessing Breast Cancer Risks to Improve Care for an Increased-Risk Population within Eastern North Carolina. North Carolina Medical Journal. 83(3). 221–228. 1 indexed citations

10.

Lin, Grace A., Julia R. Trosman, Michael P. Douglas, et al.. (2021). Influence of payer coverage and out‐of‐pocket costs on ordering of NGS panel tests for hereditary cancer in diverse settings. Journal of Genetic Counseling. 31(1). 130–139. 21 indexed citations

11.

Trosman, Julia R., Michael P. Douglas, Su‐Ying Liang, et al.. (2020). Insights From a Temporal Assessment of Increases in US Private Payer Coverage of Tumor Sequencing From 2015 to 2019. Value in Health. 23(5). 551–558. 10 indexed citations

12.

Wortman, Katy, Karen E. Kinahan, Frank J. Penedo, et al.. (2019). Piloting a Survivorship Screening Tool in a Specialty Clinic for Survivors of Childhood Cancers. Journal of Adolescent and Young Adult Oncology. 9(3). 418–421. 4 indexed citations

13.

Trosman, Julia R., Christine B. Weldon, William J. Gradishar, et al.. (2018). From the Past to the Present: Insurer Coverage Frameworks for Next-Generation Tumor Sequencing. Value in Health. 21(9). 1062–1068. 18 indexed citations

14.

Trosman, Julia R., Christine B. Weldon, Michael P. Douglas, et al.. (2017). Decision Making on Medical Innovations in a Changing Health Care Environment: Insights from Accountable Care Organizations and Payers on Personalized Medicine and Other Technologies. Value in Health. 20(1). 40–46. 15 indexed citations

15.

Trosman, Julia R., Christine B. Weldon, Michael P. Douglas, et al.. (2017). Payer Coverage for Hereditary Cancer Panels: Barriers, Opportunities, and Implications for the Precision Medicine Initiative. Journal of the National Comprehensive Cancer Network. 15(2). 219–228. 35 indexed citations

16.

Phillips, Kathryn A., Patricia A. Deverka, Julia R. Trosman, et al.. (2017). Payer coverage policies for multigene tests. Nature Biotechnology. 35(7). 614–617. 36 indexed citations

17.

Weldon, Christine B., Sarah M. Friedewald, Swati Kulkarni, et al.. (2016). Radiology as the Point of Cancer Patient and Care Team Engagement: Applying the 4R Model at a Patient’s Breast Cancer Care Initiation. Journal of the American College of Radiology. 13(12). 1579–1589. 13 indexed citations

18.

Dervan, Andrew, Patricia A. Deverka, Julia R. Trosman, et al.. (2016). Payer decision making for next-generation sequencing–based genetic tests: insights from cell-free DNA prenatal screening. Genetics in Medicine. 19(5). 559–567. 20 indexed citations

19.

Trosman, Julia R., et al.. (2015). Availability and payer coverage of BRCA1/2 tests and gene panels. Nature Biotechnology. 33(9). 900–902. 19 indexed citations

20.

Trosman, Julia R., Christine B. Weldon, Robin Kate Kelley, & Kathryn A. Phillips. (2015). Challenges of Coverage Policy Development for Next-Generation Tumor Sequencing Panels: Experts and Payers Weigh In. Journal of the National Comprehensive Cancer Network. 13(3). 311–318. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact